Kristiina Takkinen

Dr. Kristiina Takkinen

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2022 in World Allergy Organization Journal
Verified
Journal Article
Open access
SJSebastian A. Jensen
Sebastian A. Jensen
AFAlessandro Fiocchi
Alessandro Fiocchi
Ton BaarsTon Baars
Ton Baars
GJGalateja Jordakieva
Galateja Jordakieva
ANAnna Nowak-Wegrzyn
Anna Nowak-Wegrzyn
EJErika Jensen-Jarolim
Erika Jensen-Jarolim
The immunopathogenesis of cow's milk protein allergy (CMPA) is based on different mechanisms related to immune recognition of protein epitopes, which are affected by industrial processing. The purpose of this WAO DRACMA paper is to: (i) give a comprehensive overview of milk protein allergens, (ii) to review their immunogenicity and allergenicity in the context of industrial processing, and (iii) to review the milk-related immune mechanisms triggering IgE-mediated immediate type hypersensitivity reactions, mixed reactions and non-IgE mediated hypersensitivities. The main cow's milk allergens - α-lactalbumin, β-lactoglobulin, serum albumin, caseins, bovine serum albumins, and others - may determine allergic reactions through a range of mechanisms. All marketed milk and milk products have undergone industrial processing that involves heating, filtration, and defatting. Milk processing results in structural changes of immunomodulatory proteins, leads to a loss of lipophilic compounds in the matrix, and hence to a higher allergenicity of industrially processed milk products. Thereby, the tolerogenic capacity of raw farm milk, associated with the whey proteins α-lactalbumin and β-lactoglobulin and their lipophilic ligands, is lost. The spectrum of immunopathogenic mechanisms underlying cow's milk allergy (CMA) is wide. Unprocessed, fresh cow's milk, like human breast milk, contains various tolerogenic factors that are impaired by industrial processing. Further studies focusing on the immunological consequences of milk processing are warranted to understand on a molecular basis to what extent processing procedures make single milk compounds into allergens.

9 June 2011 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
TRTiina A Riihimäki
Tiina A Riihimäki
SHSoili Hiltunen
Soili Hiltunen
MRMartina Rangl
Martina Rangl
HNHenri R Nordlund
Henri R Nordlund
JMJuha Ae Määttä
Juha Ae Määttä
Vesa HytönenVesa Hytönen
Vesa Hytönen
Background: Engineered proteins, with non-immunoglobulin scaffolds, have become an important alternative to antibodies in many biotechnical and therapeutic applications. When compared to antibodies, tailored proteins may provide advantageous properties such as a smaller size or a more stable structure. Results: Avidin is a widely used protein in biomedicine and biotechnology. To tailor the binding properties of avidin, we have designed a sequence-randomized avidin library with mutagenesis focused at the loop area of the binding site. Selection from the generated library led to the isolation of a steroid-binding avidin mutant (sbAvd-1) showing micromolar affinity towards testosterone (Kd ~ 9 μM). Furthermore, a gene library based on the sbAvd-1 gene was created by randomizing the loop area between β-strands 3 and 4. Phage display selection from this library led to the isolation of a steroid-binding protein with significantly decreased biotin binding affinity compared to sbAvd-1. Importantly, differential scanning calorimetry and analytical gel-filtration revealed that the high stability and the tetrameric structure were preserved in these engineered avidins. Conclusions: The high stability and structural properties of avidin make it an attractive molecule for the engineering of novel receptors. This methodology may allow the use of avidin as a universal scaffold in the development of novel receptors for small molecules.

15 October 2011 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JHJarkko J. Heikkinen
Jarkko J. Heikkinen
LKLiisa Kivimäki
Liisa Kivimäki
JMJuha A.E. Määttä
Juha A.E. Määttä
IMInka Mäkelä
Inka Mäkelä
LHLeena Hakalahti
Leena Hakalahti
OHOsmo Hormi
Osmo Hormi

31 August 2023 in Foods
Verified
Journal Article
Open access
PDF file
EGEduardo Garcia-Calvo
Eduardo Garcia-Calvo
AGAina García-García
Aina García-García
SRSantiago Rodriguez
Santiago Rodriguez
KTKristiina Takkinen
Kristiina Takkinen
MSMartín de Santos Martín de Santos
Martín de Santos Martín de Santos
TGTeresa García
Teresa García
Gluten is the main fraction of wheat proteins. It is widely used in the food industry because of the properties that are generated in the dough, but it is also able to trigger diseases like allergies, autoimmunity processes (such as celiac disease), and intolerances in sensitized persons. The most effective therapy for these diseases is the total avoidance of gluten in the diet because it not only prevents damage but also enhances tissue healing. To ensure the absence of gluten in food products labeled as gluten-free, accurate detection systems, like immunoassays, are required. In this work, four recombinant Fab antibody fragments, selected by phage display technology, were produced and tested for specificity and accuracy against gluten in experimental flour mixtures and commercial food products. A high-affinity probe (Fab-C) was identified and characterized. An indirect ELISA test was developed based on Fab-C that complied with the legal detection limits and could be applied in the assessment of gluten-free diets.

27 May 2015 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
JHJaana Haka
Jaana Haka
MNMerja H. Niemi
Merja H. Niemi
KIKristiina Iljin
Kristiina Iljin
VRVanga Siva Reddy
Vanga Siva Reddy
KTKristiina Takkinen
Kristiina Takkinen
MLMarja-Leena Laukkanen
Marja-Leena Laukkanen
Around 3–5% of the population suffer from IgE-mediated food allergies in Western countries and the number of food-allergenic people is increasing. Individuals with certain pollen allergies may also suffer from a sensitisation to proteins in the food products. As an example a person sensitised to the major birch pollen allergen, Bet v 1, is often sensitised to its homologues, such as the major allergens of apple, Mal d 1, and celery, Api g 1, as well. Development of tools for the reliable, sensitive and quick detection of allergens present in various food products is essential for allergic persons to prevent the consumption of substances causing mild and even life-threatening immune responses. The use of monoclonal antibodies would ensure the specific detection of the harmful food content for a sensitised person. Mouse IgG antibody libraries were constructed from immunised mice and specific recombinant antibodies for Mal d 1 and Api g 1 were isolated from the libraries by phage display. More detailed characterisation of the resulting antibodies was carried out using ELISA, SPR experiments and immunoprecipitation assays. The allergen-specific Fab fragments exhibited high affinity towards the target recombinant allergens. Furthermore, the Fab fragments also recognised native allergens from natural sources. Interestingly, isolated Mal d 1-specific antibody bound also to Bet v 1, the main allergen eliciting the cross-reactivity syndrome between the birch pollen and apple. Despite the similarities in Api g 1 and Bet v 1 tertiary structures, the isolated Api g 1-specific antibodies showed no cross-reactivity to Bet v 1. Here, high-affinity allergen-specific recombinant antibodies were isolated with interesting binding properties. With further development, these antibodies can be utilised as tools for the specific and reliable detection of allergens from different consumable products. This study gives new preliminary insights to elucidate the mechanism behind the pollen-food syndrome and to study the IgG epitope of the allergens.

1 January 2001
Verified
Book Chapter
Closed access
PDF file
KTKristiina Takkinen
Kristiina Takkinen
AHAri Hemminki
Ari Hemminki
HSHans Söderlund
Hans Söderlund